143557-91-9Relevant articles and documents
Bioorthogonal Self-Immolative Linker Based on Grob Fragmentation
Avenoza, Alberto,Bernardes, Gon?alo J. L.,Busto, Jesús H.,Corzana, Francisco,Ferhati, Xhenti,García-Sanmartín, Josune,Garrido, Pablo,Guerreiro, Ana,Jiménez-Moreno, Ester,Martínez, Alfredo,Peregrina, Jesús M.,Salas-Cubero, Marina
supporting information, p. 8580 - 8584 (2021/11/17)
A self-immolative bioorthogonal conditionally cleavable linker based on Grob fragmentation is described. It is derived from 1,3-aminocyclohexanols and allows the release of sulfonate-containing compounds in aqueous media. Modulation of the amine pKa promo
AZABENZIMIDAZOLE COMPOUNDS AND PHARMACEUTICAL
-
Paragraph 0360, (2021/03/18)
The purpose of the present invention is to provide compounds having an M3 PAM action. Examples of the present invention include azabenzimidazole compounds represented, for example, by formula [I], and pharmacologically acceptable salts thereof. These comp
THERAPEUTICALLY ACTIVE BICYCLIC-SULPHONAMIDES AND PHARMACEUTICAL COMPOSITIONS
-
Paragraph 0068, (2019/05/18)
Pharmaceutical compounds have a bicyclic-sulphonamide structure and pharmaceutical compositions including the compounds may be used in therapy as brain-cell-death protectants and may be used, for example, in the treatment of chronic neurodegenerative diseases. The compounds are active as inhibitors of N-acylethanolamine-hydrolysing acid amidase (NAAA) and may be used for the therapeutic treatment and prevention of pain and inflammatory disorders and other disorders which benefit from the modulation of fatty acid ethanolamides, particularly palmitoylethanolamide (PEA).